Medical oncology
Service
University of Montpellier
Montpellier, FranciaPublications in collaboration with researchers from University of Montpellier (2)
2023
-
Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer
Frontiers in Cell and Developmental Biology, Vol. 11
-
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
Annals of Oncology, Vol. 34, Núm. 10, pp. 920-933